How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Close this folderPart II: Key components of a national drug policy
Open this folder and view contents4. Selection of essential drugs
Open this folder and view contents5. Affordability
Close this folder6. Drug financing
View the document6.1 Challenges
View the document6.2 Drug financing options
Open this folder and view contents7. Supply systems
Open this folder and view contents8. Drug regulation
Open this folder and view contents9. Rational use of drugs
Open this folder and view contents10. Research
Open this folder and view contents11. Human resources development
Open this folder and view contents12. Monitoring and evaluation
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover

6. Drug financing

Key policy issues

Drug financing is another essential component of policies to improve access to essential drugs. Key policy issues are:

• commitment to measures to improve efficiency and reduce waste;
• increased government funding for priority diseases, and for the poor and disadvantaged;
• promotion of drug reimbursements as part of public and private health insurance schemes;
• use and scope of user charges as a (temporary) drug financing option;
• use of and limits of development loans for drug financing;
• guidelines for drug donations.

Countries vary greatly with respect to income levels, population, health care expenditure and other relevant factors. National spending on pharmaceuticals may vary from US$ 2 to US$ 400 per capita per year. Questions related to drug financing have become increasingly crucial in the formulation and implementation of national drug policies.34

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017